220 related articles for article (PubMed ID: 18693280)
21. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Sharp A; Pichert G; Lucassen A; Eccles D
Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
[TBL] [Abstract][Full Text] [Related]
22. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance.
Caligo MA; Bonatti F; Guidugli L; Aretini P; Galli A
Hum Mutat; 2009 Jan; 30(1):123-33. PubMed ID: 18680205
[TBL] [Abstract][Full Text] [Related]
23. The BRCA2 genetic variant IVS7 + 2T-->G is a mutation.
Pyne MT; Brothman AR; Ward B; Pruss D; Hendrickson BC; Scholl T
J Hum Genet; 2000; 45(6):351-7. PubMed ID: 11185744
[TBL] [Abstract][Full Text] [Related]
24. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from "Uncertain Significance" to "Pathogenic" based on minigene assays and clinical evidence.
Ning Y; Zhang Y; Tian T; Chen Y; Wang J; Lei K; Cui Z
J Cancer Res Clin Oncol; 2024 Feb; 150(2):62. PubMed ID: 38300310
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic validation of unique germline intronic variants of RB1 in retinoblastoma patients using minigenes.
Gámez-Pozo A; Palacios I; Kontic M; Menéndez I; Camino I; García-Miguel P; Abelairas J; Pestaña A; Alonso J
Hum Mutat; 2007 Dec; 28(12):1245. PubMed ID: 18000883
[TBL] [Abstract][Full Text] [Related]
26. Intronic mutations in the L1CAM gene may cause X-linked hydrocephalus by aberrant splicing.
Hübner CA; Utermann B; Tinschert S; Krüger G; Ressler B; Steglich C; Schinzel A; Gal A
Hum Mutat; 2004 May; 23(5):526. PubMed ID: 15108295
[TBL] [Abstract][Full Text] [Related]
27. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model.
Yang Y; Swaminathan S; Martin BK; Sharan SK
Hum Mol Genet; 2003 Sep; 12(17):2121-31. PubMed ID: 12915465
[TBL] [Abstract][Full Text] [Related]
28. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
Lovelock PK; Healey S; Au W; Sum EY; Tesoriero A; Wong EM; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian SV; Goldgar D; Lindeman GJ; Visvader JE; Couch FJ; Henderson BR; Southey M; Chenevix-Trench G; Spurdle AB; Brown MA;
J Med Genet; 2006 Jan; 43(1):74-83. PubMed ID: 15923272
[TBL] [Abstract][Full Text] [Related]
29. Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.
Lovelock PK; Wong EM; Sprung CN; Marsh A; Hobson K; French JD; Southey M; Sculley T; Pandeya N; Brown MA; Chenevix-Trench G; Spurdle AB; McKay MJ;
Breast Cancer Res Treat; 2007 Sep; 104(3):257-66. PubMed ID: 17063265
[TBL] [Abstract][Full Text] [Related]
30. SNPSplicer: systematic analysis of SNP-dependent splicing in genotyped cDNAs.
ElSharawy A; Manaster C; Teuber M; Rosenstiel P; Kwiatkowski R; Huse K; Platzer M; Becker A; Nürnberg P; Schreiber S; Hampe J
Hum Mutat; 2006 Nov; 27(11):1129-34. PubMed ID: 16937379
[TBL] [Abstract][Full Text] [Related]
31. Characterization of two novel BRCA1 germ-line mutations involving splice donor sites.
Brose MS; Volpe P; Paul K; Stopfer JE; Colligon TA; Calzone KA; Weber BL
Genet Test; 2004; 8(2):133-8. PubMed ID: 15345110
[TBL] [Abstract][Full Text] [Related]
32. Automated splicing mutation analysis by information theory.
Nalla VK; Rogan PK
Hum Mutat; 2005 Apr; 25(4):334-42. PubMed ID: 15776446
[TBL] [Abstract][Full Text] [Related]
33. Implications of a novel cryptic splice site in the BRCA1 gene.
Hoffman JD; Hallam SE; Venne VL; Lyon E; Ward K
Am J Med Genet; 1998 Nov; 80(2):140-4. PubMed ID: 9805131
[TBL] [Abstract][Full Text] [Related]
34. U1-like snRNAs lacking complementarity to canonical 5' splice sites.
Kyriakopoulou C; Larsson P; Liu L; Schuster J; Söderbom F; Kirsebom LA; Virtanen A
RNA; 2006 Sep; 12(9):1603-11. PubMed ID: 16829670
[TBL] [Abstract][Full Text] [Related]
35. Alterations of pre-mRNA splicing in cancer.
Kalnina Z; Zayakin P; Silina K; Linē A
Genes Chromosomes Cancer; 2005 Apr; 42(4):342-57. PubMed ID: 15648050
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of in silico splice tools for decision-making in molecular diagnosis.
Houdayer C; Dehainault C; Mattler C; Michaux D; Caux-Moncoutier V; Pagès-Berhouet S; d'Enghien CD; Laugé A; Castera L; Gauthier-Villars M; Stoppa-Lyonnet D
Hum Mutat; 2008 Jul; 29(7):975-82. PubMed ID: 18449911
[TBL] [Abstract][Full Text] [Related]
37. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene.
Flomen R; Knight J; Sham P; Kerwin R; Makoff A
Nucleic Acids Res; 2004; 32(7):2113-22. PubMed ID: 15087490
[TBL] [Abstract][Full Text] [Related]
38. A Finnish BRCA1 exon 12 4216-2nt A to G splice acceptor site mutation causes aberrant splicing and frameshift, leading to protein truncation.
Hartikainen JM; Pirskanen MM; Arffman AH; Ristonmaa UK; Mannermaa AJ
Hum Mutat; 2000 Jan; 15(1):120. PubMed ID: 10612843
[No Abstract] [Full Text] [Related]
39. An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome.
Müller JS; Stucka R; Neudecker S; Zierz S; Schmidt C; Huebner A; Lochmüller H; Abicht A
Neurology; 2005 Aug; 65(3):463-5. PubMed ID: 16087917
[TBL] [Abstract][Full Text] [Related]
40. Can donor splice site recognition occur without the involvement of U1 snRNP?
Raponi M; Baralle D
Biochem Soc Trans; 2008 Jun; 36(Pt 3):548-50. PubMed ID: 18482005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
